Q4 2020 Imricor Medical Systems Inc Earnings Call Transcript

Jan 27, 2021 / 10:00PM GMT
Carrie Barrack -

Well, hello, everyone, and welcome to Imricor's quarterly results call for the period ended 31 December 2020. My name is Carrie Barrack, and I'll be moderating your call today. I'm pleased to be joined by Steve Wedan, Imricor's CEO; and Lori Milbrandt, Imricor's CFO. Steve and Lori will provide you with a brief business update, followed by question-and-answer session, and I'll give you instructions on how to ask a question at the end of the briefing.

With that, I'll hand over to Steve.

Steve Wedan - Imricor Medical Systems, Inc. - CEO, President & Executive Chairman

Thanks, Carrie, and thank you, everyone, for joining us today. This morning, Imricor released its appendix 4C for the fourth quarter of 2020, and we'd like to discuss these results as well as provide you with a business update, particularly given the COVID-19 situation in Europe and its impact on our lab rollout plans. Lori will begin with presenting the quarterly cash flow results.

Lori Milbrandt - Imricor Medical Systems, Inc. - CFO & VP of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot